Biochemistry
-
Protonation states in SARS-CoV-2 main protease mapped by neutron crystallography
This article has 8 authors:Reviewed by ScreenIT
-
The repurposed drugs suramin and quinacrine inhibit cooperatively in vitro SARS-CoV-2 3CL pro
This article has 6 authors:Reviewed by ScreenIT
-
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
This article has 10 authors:Reviewed by ScreenIT
-
Conformational diversity of CDR region during affinity maturation determines the affinity and stability of Sars-Cov-1 VHH-72 nanobody
This article has 1 author:Reviewed by ScreenIT
-
Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication in vitro
This article has 4 authors:Reviewed by ScreenIT
-
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
This article has 4 authors:Reviewed by ScreenIT
-
High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme
This article has 5 authors:Reviewed by ScreenIT
-
SARS-CoV-2 spike-glycoprotein processing at S1/S2 and S2’and shedding of the ACE2 viral receptor: roles of Furin and TMPRSS2 and implications for viral infectivity and cell-to-cell fusion
This article has 18 authors:Reviewed by ScreenIT
-
Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L
This article has 19 authors:Reviewed by ScreenIT
-
Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules
This article has 15 authors:Reviewed by ScreenIT